logo
Book a meeting
ViVita Technologies

Vi Vita Technologies

Other, 1949 5th St, Davis, California, 95616, United States, 1-10 Employees

vivitatechnologies.com

  • LinkedIn

phone no Phone Number: +13*********

Who is VIVITA TECHNOLOGIES

BIOMATERIALS ENABLING REGENERATIVE MEDICINE Imagine if there was no need for an organ transplant waiting list or anti-rejection medication because we could use robust and long-lasting org...

Read More

lock icon Get Full Access
map
  • 1949 5th St, Davis, California, 95616, United States Headquarters: 1949 5th St, Davis, California, 95616, United States
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • Maelene Wong CEO:   Maelene Wong

industries-icon Industry: Other

SIC SIC Code: 3691

checked-icon Does something look wrong? Fix it. | View contact records from VIVITA TECHNOLOGIES

ViVita Technologies Org Chart and Mapping

Maelene Wong

Maelene Wong

Chief Executive Officer, Co-Founder

See Full Org Chart arrow
email-formate-icon
View Email Formats for ViVita Technologies
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding ViVita Technologies

Answer: ViVita Technologies's headquarters are located at 1949 5th St, Davis, California, 95616, United States

Answer: ViVita Technologies's phone number is +13*********

Answer: ViVita Technologies's official website is https://vivitatechnologies.com

Answer: ViVita Technologies's revenue is Under $1 Million

Answer: ViVita Technologies's SIC: 3691

Answer: ViVita Technologies has 1-10 employees

Answer: ViVita Technologies is in Other

Answer: ViVita Technologies contact info: Phone number: +13********* Website: https://vivitatechnologies.com

Answer: BIOMATERIALS ENABLING REGENERATIVE MEDICINE Imagine if there was no need for an organ transplant waiting list or anti-rejection medication because we could use robust and long-lasting organ and tissue replacements from animals without fear of immune rejection. ViVita addresses this need using its patented SPEAR Process to prepare human immune-compatible animal tissues that retain important structural and bioactive features needed for successful transplantation and performance over a patients lifetime. ViVitas initial productBARE Patchwill enable a new generation of regenerative replacement heart valves that avoids the limited longevity and need for repeat replacement surgeries associated with current valve bioprostheses.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access